Trademark: 79074243
Word
MTM
Status
Dead
Status Code
404
Status Date
Monday, August 5, 2019
Serial Number
79074243
Registration Number
3818640
Registration Date
Tuesday, July 13, 2010
Mark Type
3000
Filing Date
Wednesday, August 5, 2009
Published for Opposition
Tuesday, April 27, 2010
Cancellation Date
Monday, August 5, 2019

Trademark Owner History
Roche mtm laboratories AG - Original Registrant
MTM Laboratories AG - Owner At Publication

Classifications
1 Chemicals used in industry and science, diagnostic preparations, reagents and chemical test kits comprised of reagents for chemical analyses and reagents for medical research use for detection of cancerous conditions, neoplastic conditions, inflammatory conditions, infectious conditions, degenerative conditions, genetically aberrant or diseased conditions, proliferatively aberrant or diseased conditions, vascular disease conditions, premalignant conditions, malignant conditions, cancer and inborn errors for scientific or research use
5 Pharmaceutical and veterinary preparations, namely, pharmaceutical preparations for the treatment and prevention of neoplastic, inflammatory, infectious, degenerative, genetic, proliferative and vascular diseases and for the treatment of premalignant and malignant cancerous conditions, cancer and inborn errors; veterinary preparations for the treatment and prevention of neoplastic, inflammatory, infectious, degenerative, genetic and proliferative and vascular diseases and for the treatment of premalignant and malignant cancerous conditions, cancer and inborn errors in livestock, cattle, pigs, horses, deer, elk, moose, sheep, dogs, cats, mice, rats, monkeys, apes and birds; medical diagnostic reagents and kits comprised of medical diagnostic reagents and assays for detection of cancer and neoplastic, inflammatory, infectious, degenerative, genetic, proliferative and vascular diseases and for the detection of premalignant and malignant cancerous conditions, cancer and inborn errors; medical diagnostic preparations, namely, in-vitro and in-vivo diagnostic test kits, diagnostic immunocytochemical kits, diagnostic immunohistochemical kits, diagnostic histology kits, diagnostic cytology kits, diagnostic liquid-immuno-assay kits, diagnostic solid-phase immuno-assay kits, diagnostic strip-tests, diagnostic dip-stick-tests, point of care tests, diagnostic lateral-flow assay kits, diagnostic flow-through assay kits, diagnostic immuno-chromatographic kits, all of the above-mentioned kits being for use in early diagnosis, prognosis, grading, monitoring, staging, predictive therapy guidance, patient stratification or therapy guidance of premalignant and malignant conditions, cancer, inborn errors and infectious, genetic, proliferative or vascular diseases
10 Medical diagnostic testing machines, namely, point-of-care testing machines, diagnostic liquid-immuno-assay machines, diagnostic immunocytochemical machines, diagnostic immunohistochemical machines, diagnostic histology machines, diagnostic cytology machines, diagnostic solid-phase immuno assay machines, diagnostic ELISA testing machines, diagnostic immuno-chromatographic machines, all of the aforementioned machines being used to analyze and/or provide diagnostic test results and used in connection with early diagnosis, prognosis, grading, monitoring, staging, predictive therapy guidance, patient stratification or therapy guidance of premalignant and malignant conditions, cancer, inborn errors and infectious and genetic diseases associated with cancer, proliferative diseases associated with neoplastics and dysplastic conditions or vascular diseases as indicated above; medical diagnostic equipment, namely, containers specially designed for storing and transporting medical samples in the nature of tubes, multiwell plates, columns, strips, sticks and brushes, and medical syringes, needles for medical use, spatulas for medical samples and medical diagnostic testing, and medical diagnostic testing swabs, cloths and tampons, all for use in sampling, storing, transporting, preparing, enriching, concentrating, testing, analyzing and evaluating biological material and samples in connection with early diagnosis, prognosis, grading, monitoring, staging, predictive therapy guidance, patient stratification and therapy guidance of premalignant and malignant conditions, cancer, inborn errors and infectious, genetic, proliferative and vascular diseases as indicated above; medical diagnostic nucleic acid detection machines, medical diagnostic nucleic acid amplification machines, medical diagnostic immuno-histology machines and medical diagnostic immuno-cytology machines all used to analyze and/or provide diagnostic test results and used in connection with early diagnosis, prognosis, grading, monitoring, staging, predictive therapy guidance, patient stratification or therapy guidance of premalignant and malignant conditions, cancer, inborn errors and infectious and genetic diseases associated with cancer, proliferative diseases associated with neoplastics and dysplastic conditions or vascular diseases as indicated above; medical diagnostic apparatuses and instruments, namely, hand-held, table-top and floor-standing centrifugal, gravitational-separating, electrophoretic, chromatographic, conductometric, potentiometric, spectrometric, spectro-photometric, radiologic electromagnetic-resonance, histological, microscopic and in-vivo-imaging machines and apparatuses for use in preparing, enriching, concentrating, testing, analyzing and evaluating of biological material and samples in connection with early diagnosis, prognosis, grading, monitoring, staging, predictive therapy guidance, patient stratification and therapy guidance of premalignant and malignant conditions, cancer, inborn errors and infectious, genetic, proliferative and vascular diseases as indicated above for clinical and medical laboratory use
42 Scientific and technological services and research and design relating thereto in the fields of chemistry, biology, molecular biology, pharmaceutics, and pharmacogenomics; industrial analysis and research services in the fields of chemistry, biology, molecular biology, pharmaceutics, and pharmacogenomics, design and development of computer hardware and software, scientific analysis in the fields of chemistry, biology and molecular biology, laboratory research in the field of molecular biology; laboratory research in the fields of pharmaceutics and food technology; providing research in the fields of pharmaceutical, chemical and diagnostic research; research and development of pharmaceutical products and substances for others; scientific research in the nature of scientific information research services; chemical, biological, molecular biology and pharmacogenomic analysis services
44 Medical services, veterinary services, medical diagnostic services and provision of medical diagnostic information in the field of detection of neoplastic, inflammatory, infectious, degenerative, genetic, proliferative and vascular diseases, premalignant and malignant cancerous conditions, cancer and inborn errors; veterinary diagnostic services and provision of veterinary diagnostic information in the field of detection of neoplastic, inflammatory, infectious, degenerative, genetic, proliferative and vascular diseases, premalignant and malignant cancerous conditions, cancer and inborn errors in livestock, cattle, pigs, horses, deer, elk, moose, sheep, dogs, cats, mice, rats, monkeys, apes and birds
Color is not claimed as a feature of the mark.
The mark consists of "MTM" with circular belt.

Trademark Events
Mar 6, 2020
Notification Of Effect Of Cancellation Of Intl Reg Mailed
Mar 6, 2020
Death Of International Registration
Nov 17, 2017
Total Invalidation Processed By The Ib
Oct 19, 2017
Total Invalidation Of Reg Ext Protection Sent To Ib
Oct 19, 2017
Invalidation Processed
Oct 17, 2017
Total Invalidation Of Reg Ext Protection Created
Feb 17, 2017
Cancelled Section 71
Feb 13, 2013
Final Decision Transaction Processed By Ib
Mar 2, 2012
Change Of Name/Address Rec'd From Ib
Oct 22, 2010
Final Disposition Notice Sent To Ib
Oct 22, 2010
Final Disposition Processed
Oct 14, 2010
Final Disposition Notice Created, To Be Sent To Ib
Jul 13, 2010
Registered-Principal Register
Apr 27, 2010
Official Gazette Publication Confirmation E-Mailed
Apr 27, 2010
Published For Opposition
Mar 22, 2010
Law Office Publication Review Completed
Mar 18, 2010
Approved For Pub - Principal Register
Mar 4, 2010
Correction From Ib Entered - No Review Required
Feb 22, 2010
Correction Transaction Received From Ib
Feb 22, 2010
Teas/Email Correspondence Entered
Feb 22, 2010
Correspondence Received In Law Office
Feb 22, 2010
Assigned To Lie
Jan 22, 2010
Teas Change Of Correspondence Received
Jan 22, 2010
Teas Response To Office Action Received
Dec 25, 2009
Refusal Processed By Ib
Dec 1, 2009
Non-Final Action Mailed - Refusal Sent To Ib
Dec 1, 2009
Refusal Processed By Mpu
Dec 1, 2009
Non-Final Action (Ib Refusal) Prepared For Review
Nov 30, 2009
Non-Final Action Written
Nov 27, 2009
Non-Final Action (Ib Refusal) Withdrawn For Review
Nov 26, 2009
Non-Final Action (Ib Refusal) Prepared For Review
Nov 25, 2009
Non-Final Action Written
Nov 21, 2009
Application Filing Receipt Mailed
Nov 17, 2009
Assigned To Examiner
Nov 17, 2009
New Application Office Supplied Data Entered In Tram
Nov 12, 2009
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24